Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published-Ahead-of-Print December 27, 2006, DOI:10.2164/jandrol.106.002386

This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
28/3/361    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hardy, M. P.
Right arrow Articles by Schlegel, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardy, M. P.
Right arrow Articles by Schlegel, P. N.

Editorial Preface

Matt P. Hardy * and Peter N. Schlegel

* To whom correspondence should be addressed. E-mail: hardy{at}popcbr.rockefeller.edu.

Male contraception has been limited to use of the condom and vasectomy. The challenge of developing a new male contraceptive has loomed as a goal in the field of andrology for many years. In 2006, at the most recent, 10th Summit Meeting on Hormonal Male Contraception in New York, a set of guidelines was drafted and released to provide benchmarks for future development and testing of hormonal methods. In this issue we are reprinting the Guidelines.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by The American Society of Andrology.